Skip To Main Content
Thomas Callender on Muck Rack

Thomas Callender

As seen in: Nature, PLOS, PLOS Medicine, The BMJ, Yahoo, The San Diego Union-Tribune, The Lancet, Stars and Stripes, Breaking Defense, Annals of Internal Medicine and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Thomas

Contact Thomas, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The benefits, harms, and cost-effectiveness of age-based and risk-stratified screening for prostate cancer with MRI

|
By Thomas Callender, Caroline Moore, Elena Frangou
| medRxiv
ME receives research support from the United Kingdom's National Institute of Health Research (NIHR) UCLH / UCL Biomedical Research Centre. ME has no direct conflict of interest associated with the work presented in this paper. ME acts as an advisor/consultant to SonaCare Inc, Nina Medical, Exact Imaging and Angiodynamics Inc. CM is funded via an NIHR Research Professorship, with additional research funding from Prostate Cancer UK, Cancer Research UK and Movember.
Open in Who Shared View Duplicates (70) Issue with article?

SynthCraft: An AI partner for synthetic data generation to support data access and augmentation in healthcare

|
By Thomas Callender, Anders Boyd
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Citation: Callender T, Boyd A, Davis R, Ruhrberg Estevez S, Lavista Ferres JM, van der Schaar M (2026) SynthCraft: An AI partner for synthetic data generation to support data access and augmentation in healthcare. PLOS Digit Health 5(3): e0001290.
Open in Who Shared Issue with article?

The ethics of multi-cancer screening - Nature Medicine

|
By Thomas Callender, Anne-Marie Slowther
| Nature Verified
Multi-cancer detection tests offer a new paradigm in cancer screening — the use of a single test to simultaneously screen for many cancers — but they raise important ethical questions for their development, evaluation and possible implementation.
Open in Who Shared Issue with article?
See all 38 articles